Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results Meeting Abstract
| Authors: | Cowzer, D.; Wu, A. J. C.; Sihag, S.; Walch, H. S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; Shcherba, M.; Capanu, M.; Chou, J. F.; Nosov, A.; Yeh, R.; Tang, L. H.; Ilson, D. H.; Janjigian, Y. Y.; Molena, D.; Ku, G. Y. |
| Abstract Title: | Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301195 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4029 |
| Notes: | Meeting Abstract: 4029 -- This meeting was also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
